Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Net Cash Flow (2018 - 2025)

BioNexus Gene Lab's Net Cash Flow history spans 8 years, with the latest figure at $1.2 million for Q4 2025.

  • Quarterly results put Net Cash Flow at $1.2 million for Q4 2025, up 93.58% from a year ago — trailing twelve months through Dec 2025 was -$594790.0 (up 64.41% YoY), and the annual figure for FY2025 was -$594790.0, up 64.41%.
  • Net Cash Flow for Q4 2025 was $1.2 million at BioNexus Gene Lab, up from -$208632.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $4.5 million in Q3 2023 to a low of -$1.9 million in Q3 2024.
  • The 5-year median for Net Cash Flow is -$156150.5 (2021), against an average of $4625.4.
  • The sharpest move saw Net Cash Flow skyrocketed 1278.54% in 2023, then plummeted 12688.35% in 2025.
  • Year by year, Net Cash Flow stood at $401759.0 in 2021, then increased by 5.68% to $424563.0 in 2022, then crashed by 494.8% to -$1.7 million in 2023, then skyrocketed by 137.66% to $631218.0 in 2024, then skyrocketed by 93.58% to $1.2 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $1.2 million, -$208632.0, and -$767469.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.